Journal of Molecular Medicine

Journal

Publication Venue For

  • Ataluren suppresses a premature termination codon in an MPS I-H mouse.  100:1223-1235. 2022
  • Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.  96:1375-1385. 2018
  • The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation.  95:951-963. 2017
  • Erratum to: CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes (Journal of Molecular Medicine, (2016), 94, 11, (1255-1265), 10.1007/s00109-016-1433-0).  95:565-566. 2017
  • CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes.  94:1255-1265. 2016
  • Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats.  93:1341-1354. 2015
  • Linking adiponectin and autophagy in the regulation of breast cancer metastasis.  92:1015-1023. 2014
  • Metastasis suppressors in breast cancers: Mechanistic insights and clinical potential.  92:13-30. 2014
  • Erratum: Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor (Journal of Molecular Medicine (2010) 88: 12 (1243-1253) DOI: 10.1007/s00109-010-0669-3).  91:407-408. 2013
  • Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma.  90:1161-1171. 2012
  • The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.  90:1407-1420. 2012
  • Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54.  89:1149-1161. 2011
  • Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds.  89:985-995. 2011
  • At the crossroads of cancer and inflammation: Ras rewires an HIF-driven IL-1 autocrine loop.  89:91-94. 2011
  • Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development.  89:743-752. 2011
  • Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.  88:1243-1253. 2010
  • Tumor initiating cells in malignant gliomas: Biology and implications for therapy.  87:363-374. 2009
  • Combined effect of mutations of the GH1 gene and its proximal promoter region in a child with growth hormone neurosecretory dysfunction (GHND).  85:1005-1013. 2007
  • Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds.  85:481-496. 2007
  • Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model.  84:573-582. 2006
  • Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level.  83:440-447. 2005
  • Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.  80:595-604. 2002
  • Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAS in a mammalian translation system.  80:367-376. 2002
  • The molecular mechanisms of veto mediated regulation of alloresponsiveness.  77:519-526. 1999
  • The level of erbB2 expression predicts sensitivity to the cytotoxic effects of an intracellular anti-erbB2 sFv.  76:451-458. 1998
  • Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.  75:165-173. 1997
  • Adenoviral-mediated deliver of herpes simplex virus thymidine kinase results in tumor rduction and prolonged survival in a SCID mouse model of human ovarian carcinoma.  74:455-462. 1996
  • Paracrine interactions regulating renal microcirculatory function.  72:682-684. 1994
  • De-novo-Translokation C/E bei klinisch atypischem E-Trisomie-Syndrom [Mosaik: 46, XX/46, XX, E+, C-t (Cq-; Ep+)].  48:1188-1192. 1970

    • International Standard Serial Number (issn)

  • 0023-2173
  • 0941-0198
  • 0946-2716

    • Electronic International Standard Serial Number (eissn)

  • 1432-1440